Senior insider sale
Chief Commercial Officer at SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$44.1K
108.71K shares
What this filing means
CHEE CONLEY plans to sell 108.71K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $44.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/18/2024ACC: 0001959173-24-007916
Officer· Chief Commercial Officer
Since Sep 2021
108.71K
Shares to sell
$44.1K
Approx. market value
100K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Open Market Buy
Cash/Check
9/11/2024
50KOpen Market Buy
Cash/Check
9/10/2024
50KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/11/2024 | Open Market Buy Cash/Check | 50K | — |
9/10/2024 | Open Market Buy Cash/Check | 50K | — |
| Total | 100K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.71K
Market value
$18.2K
11/1/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
100K
Market value
$25.9K
11/18/2024
Total
Units
108.71K
Value
$44.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/1/2024 | 8.71K | $18.2K | — | Completed |
| Planned — Approximate Date | ||||
11/18/2024 | 100K | $25.9K | NASDAQ | Planned |
| Total | 108.71K | $44.1K | ||